{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:08:48Z","timestamp":1783163328747,"version":"3.54.6"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11238-z","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:27:49Z","timestamp":1764152869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular mechanisms of neurosteroids in temporal lobe epilepsy: current insights and therapeutic perspectives"],"prefix":"10.1007","volume":"53","author":[{"given":"Zainah","family":"Al-Qahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar R.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda J.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"11238_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41386-023-01626-z","volume":"49","author":"JL Maguire","year":"2024","unstructured":"Maguire JL, Mennerick S (2024) Neurosteroids: mechanistic considerations and clinical prospects. Neuropsychopharmacology 49(1):73\u201382","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"11238_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13028","volume":"34","author":"DS Reddy","year":"2022","unstructured":"Reddy DS (2022) Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. J Neuroendocrinol 34(2):e13028","journal-title":"J Neuroendocrinol"},{"issue":"9","key":"11238_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107545","volume":"26","author":"P Lorenzon","year":"2023","unstructured":"Lorenzon P et al (2023) In vivo spontaneous activity and coital-evoked inhibition of mouse accessory olfactory bulb output neurons. iScience 26(9):107545","journal-title":"iScience"},{"issue":"2","key":"11238_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13045","volume":"34","author":"D Belelli","year":"2022","unstructured":"Belelli D et al (2022) Relating neurosteroid modulation of inhibitory neurotransmission to behaviour. J Neuroendocrinol 34(2):e13045","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"11238_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.18413\/rrpharmacology.9.10015","volume":"9","author":"SO Yu","year":"2023","unstructured":"Yu SO, Veronika P (2023) The endogenic neurosteroid system and its role in the pathogenesis and therapy of mental disorders. Res Results Pharmacol 9(1):61\u201369","journal-title":"Res Results Pharmacol"},{"key":"11238_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010507","author":"E Szczurowska","year":"2022","unstructured":"Szczurowska E et al (2022) Modulation of muscarinic signalling in the central nervous system by steroid hormones and neurosteroids. Int J Mol Sci 24(1):507. https:\/\/doi.org\/10.3390\/ijms24010507","journal-title":"Int J Mol Sci"},{"key":"11238_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/life14050582","author":"I Balan","year":"2024","unstructured":"Balan I et al (2024) Neuroactive steroids, Toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders. Life 14(5): 582. https:\/\/doi.org\/10.3390\/life14050582","journal-title":"Life"},{"issue":"1","key":"11238_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00441-020-03376-6","volume":"383","author":"R Tirindelli","year":"2021","unstructured":"Tirindelli R (2021) Coding of pheromones by vomeronasal receptors. Cell Tissue Res 383(1):367\u2013386","journal-title":"Cell Tissue Res"},{"issue":"12","key":"11238_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.tem.2022.10.001","volume":"33","author":"A Wendler","year":"2022","unstructured":"Wendler A, Wehling M (2022) Many or too many progesterone membrane receptors? Clinical implications. Trends Endocrinol Metab 33(12):850\u2013868","journal-title":"Trends Endocrinol Metab"},{"key":"11238_CR10","doi-asserted-by":"crossref","unstructured":"Dolej\u0161\u00ed E et al (2021) Steroids as the novel class of high-affinity allosteric modulators of muscarinic receptors","DOI":"10.21203\/rs.3.rs-140412\/v1"},{"issue":"7","key":"11238_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102110","volume":"298","author":"YC Lin","year":"2022","unstructured":"Lin YC et al (2022) The neurosteroid pregnenolone is synthesized by a mitochondrial P450 enzyme other than CYP11A1 in human glial cells. J Biol Chem 298(7):102110","journal-title":"J Biol Chem"},{"key":"11238_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105356","volume":"153","author":"DR Seib","year":"2023","unstructured":"Seib DR et al (2023) Neurosteroids and the mesocorticolimbic system. Neurosci Biobehav Rev 153:105356","journal-title":"Neurosci Biobehav Rev"},{"key":"11238_CR13","doi-asserted-by":"crossref","unstructured":"\u041d\u0435\u043a\u0440\u0430\u0441\u043e\u0432 \u041c\u0421 et al (2025) Study of neurotropic effects of sex steroids on an experimental model of acute stress. Russian biomedical research (\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u0431\u0438\u043e\u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0435 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f) 10(1):7\u201315","DOI":"10.56871\/RBR.2025.18.29.001"},{"issue":"3","key":"11238_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.biopsych.2023.01.022","volume":"94","author":"NL Walton","year":"2023","unstructured":"Walton NL et al (2023) Impaired endogenous neurosteroid signaling contributes to behavioral deficits associated with chronic stress. Biol Psychiatry 94(3):249\u2013261","journal-title":"Biol Psychiatry"},{"key":"11238_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108087","volume":"188","author":"T Fidecicchi","year":"2024","unstructured":"Fidecicchi T et al (2024) Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives. Maturitas 188:108087","journal-title":"Maturitas"},{"key":"11238_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113075","author":"E Szczurowska","year":"2022","unstructured":"Szczurowska E et al (2022) Allosteric modulation of muscarinic receptors by cholesterol, neurosteroids and neuroactive steroids. Int J Mol Sci  23(21):13075. https:\/\/doi.org\/10.3390\/ijms232113075","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11238_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/epi.17842","volume":"65","author":"M Alshakhouri","year":"2024","unstructured":"Alshakhouri M et al (2024) Female sex steroids and epilepsy: part 1. A review of reciprocal changes in reproductive systems, cycles, and seizures. Epilepsia 65(3):556\u2013568","journal-title":"Epilepsia"},{"key":"11238_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.expneurol.2011.10.028","volume":"244","author":"S Joshi","year":"2013","unstructured":"Joshi S, Rajasekaran K, Kapur J (2013) Gabaergic transmission in temporal lobe epilepsy: the role of neurosteroids. Exp Neurol 244:36\u201342","journal-title":"Exp Neurol"},{"key":"11238_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111189","volume":"221","author":"BA Alsfouk","year":"2025","unstructured":"Alsfouk BA et al (2025) The potential therapeutic role of Berberine in treating epilepsy focusing on temporal lobe epilepsy: state of art and ongoing perspective. Brain Res Bull 221:111189","journal-title":"Brain Res Bull"},{"issue":"1","key":"11238_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00742-2","volume":"29","author":"NH Ali","year":"2023","unstructured":"Ali NH et al (2023) Autophagy and autophagy signaling in epilepsy: possible role of autophagy activator. Mol Med 29(1):142","journal-title":"Mol Med"},{"issue":"12","key":"11238_CR21","doi-asserted-by":"publisher","first-page":"10198","DOI":"10.1007\/s12035-024-04204-6","volume":"61","author":"NH Ali","year":"2024","unstructured":"Ali NH et al (2024) A mutual nexus between epilepsy and \u03b1-synuclein: a puzzle pathway. Mol Neurobiol 61(12):10198\u201310215","journal-title":"Mol Neurobiol"},{"issue":"3","key":"11238_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11064-023-04064-x","volume":"49","author":"R AlRuwaili","year":"2024","unstructured":"AlRuwaili R et al (2024) The possible role of brain-derived neurotrophic factor in epilepsy. Neurochem Res 49(3):533\u2013547","journal-title":"Neurochem Res"},{"key":"11238_CR23","doi-asserted-by":"crossref","unstructured":"Qian X et al (2022) Proteomic Analysis Reveals the Vital Role of Synaptic Plasticity in the Pathogenesis of Temporal Lobe Epilepsy. Neural Plast,\u00a0p 8511066","DOI":"10.1155\/2022\/8511066"},{"issue":"6","key":"11238_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069\u20131077","journal-title":"Epilepsia"},{"issue":"6","key":"11238_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.seizure.2014.03.003","volume":"23","author":"J S\u00e0nchez","year":"2014","unstructured":"S\u00e0nchez J et al (2014) Factors predicting the outcome following medical treatment of mesial temporal epilepsy with hippocampal sclerosis. Seizure 23(6):448\u2013453","journal-title":"Seizure"},{"issue":"2","key":"11238_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/WCO.0b013e32833735cf","volume":"23","author":"G Biagini","year":"2010","unstructured":"Biagini G, Panuccio G, Avoli M (2010) Neurosteroids and epilepsy. Curr Opin Neurol 23(2):170\u2013176","journal-title":"Curr Opin Neurol"},{"key":"11238_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2013.00115","volume":"7","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013) Role of hormones and neurosteroids in epileptogenesis. Front Cell Neurosci 7:115","journal-title":"Front Cell Neurosci"},{"key":"11238_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010088","author":"K Parekh","year":"2022","unstructured":"Parekh K, Kravets HD, Spiegel R (2022) Special considerations in the management of women with epilepsy in reproductive years. J Pers Med 12(1):88. https:\/\/doi.org\/10.3390\/jpm12010088","journal-title":"J Pers Med"},{"issue":"Suppl 9","key":"11238_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/epi.12038","volume":"53","author":"I Ferando","year":"2012","unstructured":"Ferando I, Mody I (2012) GABAA receptor modulation by neurosteroids in models of temporal lobe epilepsies. Epilepsia 53(Suppl 9):89\u2013101","journal-title":"Epilepsia"},{"issue":"2","key":"11238_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.nbd.2010.07.016","volume":"40","author":"K Rajasekaran","year":"2010","unstructured":"Rajasekaran K et al (2010) Receptors with low affinity for neurosteroids and GABA contribute to tonic inhibition of granule cells in epileptic animals. Neurobiol Dis 40(2):490\u2013501","journal-title":"Neurobiol Dis"},{"issue":"39","key":"11238_CR31","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1523\/JNEUROSCI.2877-04.2004","volume":"24","author":"Z Peng","year":"2004","unstructured":"Peng Z et al (2004) Altered expression of the delta subunit of the GABAA receptor in a mouse model of Temporal lobe epilepsy. J Neurosci 24(39):8629\u20138639","journal-title":"J Neurosci"},{"issue":"Pt 2","key":"11238_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1113\/jphysiol.2003.059246","volume":"557","author":"C Leroy","year":"2004","unstructured":"Leroy C et al (2004) Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J Physiol 557(Pt 2):473\u2013487","journal-title":"J Physiol"},{"issue":"Pt 6","key":"11238_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1093\/brain\/awn095","volume":"131","author":"A Knopp","year":"2008","unstructured":"Knopp A et al (2008) Loss of GABAergic neurons in the subiculum and its functional implications in temporal lobe epilepsy. Brain 131(Pt 6):1516\u20131527","journal-title":"Brain"},{"key":"11238_CR34","unstructured":"Jeong J (2021) Modulation of GABAA receptor by neurosteroids and protein kinases in health and disease. The University of Western Ontario (Canada)"},{"issue":"2","key":"11238_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.expneurol.2006.04.029","volume":"201","author":"G Biagini","year":"2006","unstructured":"Biagini G et al (2006) Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol 201(2):519\u2013524","journal-title":"Exp Neurol"},{"key":"11238_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249391","author":"M L\u00e9vesque","year":"2020","unstructured":"L\u00e9vesque M, Biagini G, Avoli M (2020) Neurosteroids and focal epileptic disorders. Int J Mol Sci 21(24):9391. https:\/\/doi.org\/10.3390\/ijms21249391","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11238_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/bja\/61.4.462","volume":"61","author":"S H\u00f8gskilde","year":"1988","unstructured":"H\u00f8gskilde S et al (1988) Anticonvulsive properties of pregnanolone emulsion compared with Althesin and thiopentone in mice. Br J Anaesth 61(4):462\u2013467","journal-title":"Br J Anaesth"},{"issue":"3","key":"11238_CR38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","volume":"270","author":"TG Kokate","year":"1994","unstructured":"Kokate TG, Svensson BE, Rogawski MA (1994) Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 270(3):1223\u20131229","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"11238_CR39","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0028-3908(96)00021-4","volume":"35","author":"TG Kokate","year":"1996","unstructured":"Kokate TG et al (1996) Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology 35(8):1049\u20131056","journal-title":"Neuropharmacology"},{"issue":"6","key":"11238_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1159\/000509093","volume":"111","author":"C Lucchi","year":"2021","unstructured":"Lucchi C et al (2021) Allopregnanolone and pregnanolone are reduced in the hippocampus of epileptic rats, but only allopregnanolone correlates with seizure frequency. Neuroendocrinology 111(6):536\u2013541","journal-title":"Neuroendocrinology"},{"issue":"5","key":"11238_CR41","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/epi.17561","volume":"64","author":"AM Costa","year":"2023","unstructured":"Costa AM et al (2023) Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy. Epilepsia 64(5):1376\u20131389","journal-title":"Epilepsia"},{"issue":"3","key":"11238_CR42","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1111\/epi.17887","volume":"65","author":"M Gol","year":"2024","unstructured":"Gol M et al (2024) Seizure progression is slowed by enhancing neurosteroid availability in the brain of epileptic rats. Epilepsia 65(3):e41\u2013e46","journal-title":"Epilepsia"},{"issue":"1","key":"11238_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1528-1167.2008.01971.x","volume":"50","author":"G Biagini","year":"2009","unstructured":"Biagini G et al (2009) Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 50(1):53\u201358","journal-title":"Epilepsia"},{"issue":"1","key":"11238_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yebeh.2012.05.024","volume":"25","author":"D Samba Reddy","year":"2012","unstructured":"Samba Reddy D, Ramanathan G (2012) Finasteride inhibits the disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Epilepsy Behav 25(1):92\u201397","journal-title":"Epilepsy Behav"},{"key":"11238_CR45","doi-asserted-by":"crossref","unstructured":"Pugnaghi M et al (2013) Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis. BMJ Case Rep","DOI":"10.1136\/bcr-2012-008204"},{"issue":"6","key":"11238_CR46","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1111\/epi.13772","volume":"58","author":"M Trivisano","year":"2017","unstructured":"Trivisano M et al (2017) Reduced steroidogenesis in patients with PCDH19-female limited epilepsy. Epilepsia 58(6):e91\u2013e95","journal-title":"Epilepsia"},{"issue":"4","key":"11238_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/acn3.51023","volume":"7","author":"S Joshi","year":"2020","unstructured":"Joshi S et al (2020) Reduced neurosteroid potentiation of GABA(A) receptors in epilepsy and depolarized hippocampal neurons. Ann Clin Transl Neurol 7(4):527\u2013542","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"11238_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/jnc.14550","volume":"147","author":"S Meletti","year":"2018","unstructured":"Meletti S et al (2018) Low levels of progesterone and derivatives in cerebrospinal fluid of patients affected by status epilepticus. J Neurochem 147(2):275\u2013284","journal-title":"J Neurochem"},{"issue":"9","key":"11238_CR49","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00213-023-06427-2","volume":"240","author":"DS Reddy","year":"2023","unstructured":"Reddy DS, Mbilinyi RH, Estes E (2023) Preclinical and clinical pharmacology of Brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy. Psychopharmacology 240(9):1841\u20131863","journal-title":"Psychopharmacology"},{"issue":"3","key":"11238_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/ana.25008","volume":"82","author":"ES Rosenthal","year":"2017","unstructured":"Rosenthal ES et al (2017) Brexanolone as adjunctive therapy in super-refractory status epilepticus. Ann Neurol 82(3):342\u2013352","journal-title":"Ann Neurol"},{"issue":"0 6","key":"11238_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/epi.12289","volume":"54","author":"MA Rogawski","year":"2013","unstructured":"Rogawski MA et al (2013) Neuroactive steroids for the treatment of status epilepticus. Epilepsia 54(0 6):93\u201398","journal-title":"Epilepsia"},{"issue":"10","key":"11238_CR52","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","volume":"28","author":"HP Goodkin","year":"2008","unstructured":"Goodkin HP et al (2008) Subunit-specific trafficking of GABA(A) receptors during status epilepticus. J Neurosci 28(10):2527\u20132538","journal-title":"J Neurosci"},{"key":"11238_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eplepsyres.2015.05.006","volume":"115","author":"C Behr","year":"2015","unstructured":"Behr C et al (2015) Lacosamide modulates interictal spiking and high-frequency oscillations in a model of mesial temporal lobe epilepsy. Epilepsy Res 115:8\u201316","journal-title":"Epilepsy Res"},{"key":"11238_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.seizure.2014.11.008","volume":"25","author":"M L\u00e9vesque","year":"2015","unstructured":"L\u00e9vesque M, Behr C, Avoli M (2015) The anti-ictogenic effects of Levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy. Seizure 25:18\u201325","journal-title":"Seizure"},{"key":"11238_CR55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuropharm.2017.04.020","volume":"121","author":"M L\u00e9vesque","year":"2017","unstructured":"L\u00e9vesque M et al (2017) Allopregnanolone decreases interictal spiking and fast ripples in an animal model of mesial temporal lobe epilepsy. Neuropharmacology 121:12\u201319","journal-title":"Neuropharmacology"},{"issue":"2","key":"11238_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2022.11.007","volume":"44","author":"N Yasmen","year":"2023","unstructured":"Yasmen N et al (2023) Ganaxolone for management of seizures associated with CDKL5 deficiency disorder. Trends Pharmacol Sci 44(2):128\u2013129","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"11238_CR57","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s40265-022-01724-0","volume":"82","author":"YN Lamb","year":"2022","unstructured":"Lamb YN (2022) Ganaxolone: first approval. Drugs 82(8):933\u2013940","journal-title":"Drugs"},{"key":"11238_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136096","volume":"761","author":"J Banerjee","year":"2021","unstructured":"Banerjee J et al (2021) Differential regulation of excitatory synaptic transmission in the hippocampus and anterior temporal lobe by Cyclin dependent kinase 5 (Cdk5) in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS). Neurosci Lett 761:136096","journal-title":"Neurosci Lett"},{"issue":"11","key":"11238_CR59","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/14737175.2021.1904895","volume":"21","author":"S Lattanzi","year":"2021","unstructured":"Lattanzi S, Riva A, Striano P (2021) Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy. Expert Rev Neurother 21(11):1317\u20131332","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"11238_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14656566.2024.2342413","volume":"25","author":"P Khan","year":"2024","unstructured":"Khan P et al (2024) A systematic review and meta-analysis on efficacy and safety of Ganaxolone in epilepsy. Expert Opin Pharmacother 25(5):621\u2013632","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"11238_CR61","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","volume":"48","author":"VA Pieribone","year":"2007","unstructured":"Pieribone VA et al (2007) Clinical evaluation of Ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia 48(10):1870\u20131874","journal-title":"Epilepsia"},{"issue":"3","key":"11238_CR62","volume":"5","author":"G de Jes\u00fas Aguirre-Vera","year":"2025","unstructured":"de Jes\u00fas Aguirre-Vera G et al (2025) Targeting drug-resistant epilepsy: a narrative review of five novel antiseizure medications. Int J Transl Med 5(3):31","journal-title":"Int J Transl Med"},{"issue":"1","key":"11238_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/epi4.12669","volume":"8","author":"J Meng","year":"2023","unstructured":"Meng J et al (2023) The efficacy and safety of Ganaxolone for the treatment of refractory epilepsy: a meta-analysis from randomized controlled trials. Epilepsia Open 8(1):90\u201399","journal-title":"Epilepsia Open"},{"issue":"2","key":"11238_CR64","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ana.25149","volume":"83","author":"DM Talos","year":"2018","unstructured":"Talos DM et al (2018) Mechanistic target of Rapamycin complex 1 and 2 in human temporal lobe epilepsy. Ann Neurol 83(2):311\u2013327","journal-title":"Ann Neurol"},{"issue":"2","key":"11238_CR65","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00415-023-12062-w","volume":"271","author":"Y Qi","year":"2024","unstructured":"Qi Y et al (2024) AMPK role in epilepsy: a promising therapeutic target? J Neurol 271(2):748\u2013771","journal-title":"J Neurol"},{"key":"11238_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2022.12.006","volume":"191","author":"DL Egbenya","year":"2023","unstructured":"Egbenya DL et al (2023) Synapse-specific changes in Arc and BDNF in rat hippocampus following chronic temporal lobe epilepsy. Neurosci Res 191:1\u201312","journal-title":"Neurosci Res"},{"key":"11238_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05113-y","author":"R AlRuwaili","year":"2025","unstructured":"AlRuwaili R et al (2025) Targeting of the PI3 K\/AKT\/GSK3\u03b2 pathway in Parkinson\u2019s disease: a therapeutic blueprint. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05113-y","journal-title":"Mol Neurobiol"},{"issue":"Pt 2","key":"11238_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142933","volume":"309","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM et al (2025) Targeting of AMPK\/MTOR signaling in the management of atherosclerosis: outmost leveraging. Int J Biol Macromol 309(Pt 2):142933","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"11238_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/15548627.2020.1731270","volume":"17","author":"M Ishikawa","year":"2021","unstructured":"Ishikawa M et al (2021) The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs\/GABA(A) receptors in rat glaucoma models. Autophagy 17(3):743\u2013760","journal-title":"Autophagy"},{"issue":"2","key":"11238_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","volume":"60","author":"HN Kim","year":"2012","unstructured":"Kim HN, Lee SJ, Koh JY (2012) The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem Int 60(2):125\u2013133","journal-title":"Neurochem Int"},{"issue":"7","key":"11238_CR71","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/brain\/awad048","volume":"146","author":"E Aronica","year":"2023","unstructured":"Aronica E et al (2023) Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. Brain 146(7):2694\u20132710","journal-title":"Brain"},{"issue":"1","key":"11238_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dmcn.15766","volume":"66","author":"S Amin","year":"2024","unstructured":"Amin S (2024) Rare epilepsy treatment: what is on the gene-code lottery list? Dev Med Child Neurol 66(1):6\u20137","journal-title":"Dev Med Child Neurol"},{"key":"11238_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05126-7","author":"GH Alshehri","year":"2025","unstructured":"Alshehri GH et al (2025) The AMPK\/GDF15 axis: a novel target for the neuroprotective effects of Metformin in ischemic stroke. Mol Neurobiol. 62(11):15149-15163. https:\/\/doi.org\/10.1007\/s12035-025-05126-7","journal-title":"Mol Neurobiol"},{"key":"11238_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05098-8","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM et al (2025) The effect of Metformin on astrocytes in Parkinson\u2019s disease: challenges and opportunities. Mol Neurobiol 62(11):15055-15069. https:\/\/doi.org\/10.1007\/s12035-025-05098-8","journal-title":"Mol Neurobiol"},{"issue":"8","key":"11238_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1346","volume":"12","author":"A Turkistani","year":"2024","unstructured":"Turkistani A et al (2024) Pharmacological characterization of the antidiabetic drug Metformin in atherosclerosis inhibition: a comprehensive insight. Immunity, Inflammation and Disease 12(8):e1346","journal-title":"Immunity, Inflammation and Disease"},{"issue":"1","key":"11238_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-023-00238-9","volume":"35","author":"HM Al-kuraishy","year":"2023","unstructured":"Al-kuraishy HM et al (2023) Effects of Metformin on fibroblast growth factor 21 in patients with type 2 diabetes mellitus: faraway but so close. Egypt J Intern Med 35(1):65","journal-title":"Egypt J Intern Med"},{"key":"11238_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091190","author":"E Conte","year":"2024","unstructured":"Conte E et al (2024) Therapeutic approaches to tuberous sclerosis complex: from available therapies to promising drug targets. Biomolecules 14(9):1190. https:\/\/doi.org\/10.3390\/biom14091190","journal-title":"Biomolecules"},{"issue":"12","key":"11238_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70167","volume":"30","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM et al (2024) The compelling role of brain-derived neurotrophic factor signaling in multiple sclerosis: role of BDNF activators. CNS Neurosci Ther 30(12):e70167","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"11238_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18368","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH et al (2024) BDNF\/TrkB activators in parkinson\u2019s disease: a new therapeutic strategy. J Cell Mol Med 28(10):e18368","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11238_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-025-08857-x","volume":"27","author":"SM Alqahtani","year":"2025","unstructured":"Alqahtani SM et al (2025) Unlocking Alzheimer\u2019s disease: the role of BDNF signaling in neuropathology and treatment. Neuromolecular Med 27(1):36","journal-title":"Neuromolecular Med"},{"issue":"5","key":"11238_CR81","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s12035-023-03727-8","volume":"61","author":"NH Ali","year":"2024","unstructured":"Ali NH et al (2024) The molecular pathway of p75 neurotrophin receptor (p75NTR) in parkinson\u2019s disease: the way of new inroads. Mol Neurobiol 61(5):2469\u20132480","journal-title":"Mol Neurobiol"},{"issue":"2","key":"11238_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1063","volume":"11","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM et al (2023) Pros and cons for statins use and risk of Parkinson\u2019s disease: an updated perspective. Pharmacol Res Perspect 11(2):e01063","journal-title":"Pharmacol Res Perspect"},{"key":"11238_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1217702","volume":"17","author":"EA Filimonova","year":"2023","unstructured":"Filimonova EA et al (2023) Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy. Front Neurosci 17:1217702","journal-title":"Front Neurosci"},{"key":"11238_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041758","author":"FB Almeida","year":"2021","unstructured":"Almeida FB, Barros HMT, Pinna G (2021) Neurosteroids and neurotrophic factors: what is their promise as biomarkers for major depression and PTSD? Int J Mol Sci.22(4):1758. https:\/\/doi.org\/10.3390\/ijms22041758","journal-title":"Int J Mol Sci"},{"key":"11238_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.neuroscience.2025.05.022","volume":"577","author":"K Nagpurkar","year":"2025","unstructured":"Nagpurkar K et al (2025) Neurosteroids as emerging therapeutics for treatment-resistant depression: mechanisms and clinical potential. Neuroscience 577:300\u2013314","journal-title":"Neuroscience"},{"key":"11238_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070945","author":"TA Fedotcheva","year":"2025","unstructured":"Fedotcheva TA, Shimanovsky NL (2025) Neurosteroids progesterone and dehydroepiandrosterone: molecular mechanisms of action in neuroprotection and neuroinflammation. Pharmaceuticals (Basel) 18(7):945. https:\/\/doi.org\/10.3390\/ph18070945","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11238-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:02:31Z","timestamp":1764158551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11238-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11238"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11238-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"124"}}